“Evaluating Fluoxetine’s Growth-Inhibitory Impact on Clinical Isolates of Enteric Bacteria: Harnessing Repurposing Potential”. 2023. Microbiological & Immunological Communications 2 (2): 89-96. https://doi.org/10.55627/mic.002.02.0454.